Q&A: How Chemonics went from corrective action to commercial solutions

Chemonics Executive Vice President Jamey Butcher. Screengrab from Chemonics

WASHINGTON — In 2015, the development contractor Chemonics International sent shockwaves through the U.S. aid community when it captured the largest U.S. Agency for International Development contract ever awarded and took control of a global health supply chain that undergirds the U.S. government’s largest health programs.

Two years later, Chemonics’ success appeared to have turned against it. By the spring of 2017, as Devex first reported, the indicators used to track the performance of the supply chain had declined precipitously, prompting an intervention by USAID, a U.S. congressional hearing, and intensive corrective action by the contractor itself.

Should your team be reading this?
Contact us about a group subscription to Pro.

About the author

  • Igoe michael 1

    Michael Igoe

    Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.